Celgene top products revenues 2013-2018 | Statista

This statistic reveals the revenues generated by biotech company Celgene's top products between 2013 and 2018. In 2014, one of the company's top products, Otezla, generated revenues of around 70 million U.S. dollars. Otezla's annual revenue increased up to 1.6 billion dollars until 2018. Celgene Corporation is headquartered in Summit, New Jersey. The company is specialized on drug manufacturing for cancer and inflammatory disorders.

Revenues of biotech company Celgene's top products from 2013 to 2018 (in million U.S. dollars)

Drug name (therapy area)	2013	2014	2015	2016	2017	2018
Revlimid (cancer)	4,280.3	4,980	5,801.1	6,973.6	8,187	9,685
Pomalyst/Imnovid (cancer)	305.4	679.7	983.3	1,310.7	1,614	2,040
Otezla (psoriasis)	-	69.8	471.7	1,017.2	1,279	1,608
Abraxane (cancer)	648.9	848.2	967.5	973.4	992	1,062
Other*	-	-	-	-	901	870

Loading statistic...

Download

Source

Show detailed source information?

Register for free

Already a member?

Source

Use Ask Statista Research Service

Release date

February 2019

More information

Region

Worldwide

Survey time period

2013 to 2018

Supplementary notes

Figures before 2016 were taken from previous annual reports.
No value means no data available.

Citation formats

Other statistics on the topic
Bristol-Myers Squibb

Number of active physicians in the U.S. in 2023, by specialty area

Health Professionals & Hospitals

Number of active physicians in the U.S. 2023 by specialty area

Deaths by cancer in the U.S. from 1950 to 2019 (per 100,000 population)*

State of Health

Deaths by cancer in the U.S. 1950-2019

Number of U.S. physicians in oncology specialties in 2016

Health Professionals & Hospitals

Number of oncology specialty physicians in the U.S. 2016

Top 10 pharmaceutical companies based on global oncology revenue in 2017 and 2024 (in million U.S. dollars)

Pharmaceutical Products & Market

Global oncology revenue by top ten pharmaceutical companies 2017 and 2024

Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Starter Account

The ideal entry-level account for individual users

Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references

$189 USD $149 USD / Month *

in the first 12 months

Professional Account

Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Oncology "

The most important statistics

The most important statistics

The most important statistics

The most important statistics

The most important statistics

The most important statistics

The most important statistics

The most important statistics

Other statistics that may interest you Oncology

Cancer facts

5

Oncology market

6

Companies

7

Cancer drugs

5

Research and development

6

Immuno-oncology

5

Treatment types

5

Physicians and patients

8

Further related statistics

17

Further Content: You might find this interesting as well

Statistics

Topics

Bristol-Myers Squibb

Global pharmaceutical industry

Pharmaceutical industry in the U.S.

Johnson & Johnson

Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year

Learn more about how Statista can support your business.